Cleared Traditional

K911055 - A-PORT IMPLANT VASC ACCESS SYST LINE EX...

K911055 is an FDA 510(k) clearance for A-PORT IMPLANT VASC ACCESS SYST LINE EX..., manufactured by Therex Corp.. The device is a Class 2 General Hospital device with product code LJT cleared through the Traditional 510(k) pathway after a 42-day FDA review.

K911055 · Therex Corp. · General Hospital
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Apr 1991
Decision
42d
Days
Class 2
Risk

K911055 is an FDA 510(k) clearance for the A-PORT IMPLANT VASC ACCESS SYST LINE EXT-A2 PORT. Classified as Port & Catheter, Implanted, Subcutaneous, Intravascular (product code LJT), Class II - Special Controls.

Submitted by Therex Corp. (Walpole, US). The FDA issued a Cleared decision on April 19, 1991 after a review of 42 days - a notably fast clearance cycle.

This device falls under the General Hospital FDA review panel, regulated under 21 CFR 880.5965 - the FDA general hospital device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Therex Corp. devices

FDA 510(k) Submission Details - K911055

510(k) Number K911055 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received March 08, 1991
Decision Date April 19, 1991
Days to Decision 42 days
Submission Type Traditional
Review Panel General Hospital (HO)
Summary -
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
87d faster than avg
Panel avg: 129d · This submission: 42d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

LJT Device Classification - Class 2, Special Controls

Product Code LJT Port & Catheter, Implanted, Subcutaneous, Intravascular
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 880.5965
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most General Hospital devices follow this clearance model.

Regulatory Peers - LJT Port & Catheter, Implanted, Subcutaneous, Intravascular

All 166
Devices cleared under the same product code (LJT) and FDA review panel - the closest regulatory comparables to K911055.
STRATO PLASTIC PORT INTRO KT(10 FR) LPS 7523/MODIF
K905849 · Strato Medical Corp. · Apr 1991
STRATO PLASTIC PORT INTRO(9 FR)LPS 7513/MODIFIED
K905850 · Strato Medical Corp. · Apr 1991
STRATO PLAST PORT INTRO KT(10 FR)LPS 7013/MODIFIED
K905852 · Strato Medical Corp. · Apr 1991
LIFEPORT VASCU ACCESS SYST/PORT INTRO KIT 7015
K911355 · Strato Medical Corp. · Apr 1991
STRATO LOW PROFILE PORT(LPS 1055)/MODIFICATION
K905846 · Strato Medical Corp. · Apr 1991
LIFE PT VASC ACCESS PT W/DETACH CATH(LPS 6013)MODI
K905848 · Strato Medical Corp. · Apr 1991